Reduction in Plaque Size and Reduction in Plaque Number as Differing Indices of Influenza Virus-Antibody Reactions
AUTOR(ES)
Jahiel, R. I.
RESUMO
Jahiel, R. I. (Cornell University Medical College, New York, N.Y.), and E. D. Kilbourne. Reduction in plaque size and reduction in plaque number as differing indices of influenza virus-antibody reactions. J. Bacteriol. 92:1521–1534. 1966.—The serological reactivity of an antigenically hybrid influenza virus recombinant (X-7) was studied in a heteroploid cell plaquing system in which antisera to the parental viruses NWS/(A0) and RI/5+ (A2) were incorporated in agar overlay media. Two different effects on plaque formation were found. With NWS antiserum, there was close relationship between reduction in plaque size and in plaque number [plaque inhibition (PI) pattern]. With RI/5 antiserum, plaque size reduction (PSR) occurred over a wide zone of serum dilutions without concomitant change in plaque number (PSR pattern). Several different preinoculation neutralization tests showed a strong reactivity of X-7 with NWS antisera and little if any reactivity with RI/5 antisera. We interpret the differing effects of NWS and RI/5 antisera on X-7 as indicative of the possible occurrence of different mechanisms of neutralization or of the possible participation of different surface antigens. The kinetics of PSR are consistent with the hypothesis that it results from the reaction of RI/5 antiserum with the RI/5-like neuraminidase of X-7. Studies with the antiserum-in-overlay technique of PSR and PI patterns comprise a sensitive method for quantitative antigenic analysis of plaque-forming influenza viruses.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=276453Documentos Relacionados
- Infectious virus-antibody complexes of sindbis virus.
- Macrophage Fc receptors control infectivity and neutralization of canine distemper virus-antibody complexes.
- Effect of respiratory syncytial virus and virus-antibody complexes on the oxidative metabolism of human neutrophils.
- Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin.
- Formation of an infectious virus-antibody complex with Rous sarcoma virus and antibodies directed against the major virus glycoprotein.